Searchable abstracts of presentations at key conferences in endocrinology

ea0022oc5.2 | Reproduction & Thyroid | ECE2010

The influence of cure of subclinical hyperthyroidism on diastolic diameters of heart chambers and cardiac index

Kaminski Grzegorz , Podgajny Zbigniew , Szalus Norbert

Introduction: Subclinical hyperthyroidism (SH) affects about 1% of population. The diagnosis of this disease leans on the laboratory criteria only: decreased of TSH and normal FT3 and FT4 levels. SH increases mortality mostly due to cardiovascular diseases including arrhythmia and overload of the heart. Enlarging of heart chambers is one of the cause of arrhythmia, and cardiac index is one of indicators of heart after load.Aim: To e...

ea0020p89 | Thyroid | ECE2009

Our experience in visualization of non-radioiodine-avid differentiated thyroid carcinoma (NRADTC)

Podgajny Zbigniew , Kaminski Grzegorz , Szalus Norbert

Introduction: Lack of radioiodine uptake in differentiated thyroid carcinoma (DTC) is a big diagnostic and therapeutic problem. This sign is associated with worse prognosis. In NRADTC patients with elevated thyreoglobulin levels with no evidence of disease in radioiodine scintigraphy, scintigraphy with the somatostatin analog labeled with 99mTc seems to be an alternative imaging method.Aim: Assessment of scintigraphy with the somatostatin anal...

ea0029p326 | Cardiovascular Endocrinology and Lipid Metabolism | ICEECE2012

Effect of melatonin supplementation on lipid peroxidation and on the enzymes of antioxidative system in patients with chronic coronary artery disease.

Podgajny Z. , Kot M. , Szalus N. , Mitura P. , Kaminski G.

Background: Melatonin as strong antioxidant and free radical scavenger can play important, protective role in disease in which oxidative damage is a significant component e.g.: in coronary heart disease, neoplastic disease, neurodegenerative disease. The aim of our study was determination of the effect of melatonin supplementation on malonyldialdehyde (MDA) concentration and activity of: superoxide dismutase (SOD), glutathione peroxidase (GSH-Px) and catalase (CAT) in patients...

ea0035p566 | Endocrine tumours and neoplasia | ECE2014

Primary neuroendocrine carcinoma of renal: a rare case report

Budlewski Tadeusz , Szydlarska Dorota , Szalus Norbert , Kijek Jolanta , Chrapko Beata Ewa

We report a case of local recurrence and multiple lymph node and pulmonary metastases of renal carcinoid 1 year after nephrectomy in a 61-year-old woman. Primary renal carcinoid tumor arising from renal parenchyma or renal pelvis is a rare neoplasm. The patient was incidentally found to have a mass lesion in the left kidney and left nephrectomy was performed. Histological examination including immunohistochemical for chromogranin A and synaptophysin studies confirmed the diagn...

ea0011p856 | Thyroid | ECE2006

Somatostatin receptor scintigraphy with 99mTc-HYNIC-TATE in visualization of non-radioiodine-avid differentiated thyroid carcinoma

Podgajny Z , Kaminski G , Szalus N , Kowalczyk A , Pietrzykowski J , Jaroszuk A , Siekierzynski M

Introduce: Lack of radioiodine uptake in Differentiated Thyroid Carcinoma (DTC) is a huge diagnostic and therapeutic problem. This sign is associated with worse prognosis. In patients with elevated thyroglobulin levels and with no evidence of disease on radioiodine scintigraphy, scintigraphy with somatostatin analogs can be an alternative imaging modality.The aim: Assessment of scintigraphy with the somatostatin analog 99mTc-HYNIC-TATE to visu...

ea0011p900 | Thyroid | ECE2006

Treatment of disseminated non-radioiodine - avid papillary thyroid cancer with 90Y-DOTA-TATE preparation

Szalus N , Kaminski G , Obuchowski K , Pietrzykowski J , Podgajny Z , Zagrodzka M , Dziuk E

Introduction: Lack of radioiodine uptake in Differentiated Thyroid Carcinoma is a huge diagnostic and therapeutic problem. This sign is associated with worse prognosis. DOTA-TATE preparation is a somatostatin analogue coupled with 90 Y which emites β (−) radiation. Its use in a treatment depends on excessive expression of somatostatin receptors (SSTR) in malignant tumours.The aim of the study: To present a possibility of treatment o...

ea0014oc8.5 | Neuroendocrinology clinical | ECE2007

Inoperable pituitary tumours treated with 90Y-DOTA-TATE – initial results

Kaminski Grzegorz , Szalus Norbert , Zielinski Grzegorz , Podgajny Zbigniew , Zgliczynski Wojciech , Kasperlik-Zaluska Anna , Cyperling-Kaminska Joanna , Dziuk Eugeniusz

Introduction: The patients with inoperable hormone - secreting pituitary tumours are treated with cold somatostatin analogues, but it is not always effective. DOTA-TATE preparation is a somatostatin analogue coupled with β (−) emitter 90 Y. The efficacy of the treatment is based on excessive expression of somatostatin receptors (SSTR) in these tumours.The aim of the study: To assess the feasibility of treatment of pituitary tumours ...